Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Roche Stamm is a globally leading biotechnology company headquartered in Switzerland. It focuses on the research and development of innovative pharmaceuticals and diagnostics. The objective is to create groundbreaking therapies and solutions that sustainably improve patients' lives, positioning Roche Stamm at the forefront of medical advancements.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Roche Stamm (RO) reported its Q2 2026 financial results on July 23, 2026, before the market opened. The company reported an EPS of 10.85 CHF, beating the analyst estimate of 10.33 CHF by 5.0%. Revenue for the quarter reached 15642 million CHF, and the stock price rose by 5.15% following the announcement.
Generated automatically from our data — as of 07/29/2026 Read the article →
Roche Stamm is scheduled to report its next quarterly earnings on 10/22/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Roche Stamm last reported quarterly earnings on 7/23/2026 (Q2 2026). Earnings per share (EPS) came in at 10.85 CHF.
Across its last 5 earnings reports, Roche Stamm stock moved by ±3% on average the following day. The largest reaction was +5.2% on 07/23/2026; 4 of 5 reactions were positive.
For fiscal year 2025, Roche Stamm paid a dividend of 9.80 CHF per share.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.
| Fiscal year | Dividend per share | Ex-date | Payment date |
|---|---|---|---|
| 2025 | 9.80 CHF | 3/12/2026 | 3/16/2026 |
| 2024 | 9.70 CHF | 3/27/2025 | 3/31/2025 |
| 2023 | 9.60 CHF | – | – |
| 2022 | 9.50 CHF | – | – |
| 2021 | 9.30 CHF | – | – |
Source: Roche Stamm investor relations, 5 fiscal years.
Past dividends are no guarantee of future payouts.